Similar to previous tumor findings, we also found a reduced percentage and MFI of NK cells IFN-γ, and a reduced positive percentage of granzyme B and perforin in circulating NK cells in patients with CRC, which may also favor cancer cell survival. The gene discussed is PRF1; the disease is neoplasm.